about
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanomaSpontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatmentPotential target antigens for a universal vaccine in epithelial ovarian cancer.Systematic review of medical treatment in melanoma: current status and future prospects.Primary retroperitoneal malignant melanoma: A case report.Immunotherapy of cancer in 2012.Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in adjuvant with PF-3512676 and GM-CSF in metastatic melanoma.Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccination.Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistanceHumoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2.Monitoring the production of reactive oxygen species in experimental melanomaEnhancing antimelanoma immune responses through apoptosis.Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles.
P2860
Q21245488-AD127D08-4548-4973-9CA6-F6A578134E52Q26774238-0425E32A-76DC-4432-9675-0C5BE7A42A5CQ34159451-3000CEC4-D656-441C-B8B0-9C367AE9BD53Q35584299-F5B734BB-B2F8-4EF7-9F5C-945B7FD8F553Q36121387-0C977F2F-45EE-4B4E-A367-69AC602482FEQ36243536-70BEFAB5-1167-470D-902F-2A0CAD469584Q36353361-9148EE04-C76B-4301-AA45-1803E3E531E5Q36443331-48233D17-20B8-4CFF-AAF8-B5116D711C65Q37021699-05F4E630-3A2F-43C7-9C35-3E8003ADE32EQ40204827-3258888E-77D6-4517-AA56-F60BE5944780Q41787187-2A5BC06E-7CD7-448D-85D3-BE256650BE6AQ47659517-A24D76C5-4870-4C45-BCF6-38F945F4106BQ48531728-C476D99C-BA23-450F-B28D-B8B7531E77E1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunotherapy for melanoma.
@ast
Immunotherapy for melanoma.
@en
Immunotherapy for melanoma.
@nl
type
label
Immunotherapy for melanoma.
@ast
Immunotherapy for melanoma.
@en
Immunotherapy for melanoma.
@nl
prefLabel
Immunotherapy for melanoma.
@ast
Immunotherapy for melanoma.
@en
Immunotherapy for melanoma.
@nl
P2093
P2860
P1433
P1476
Immunotherapy for melanoma.
@en
P2093
Christina J Kim
Dimitry Gabrilovich
Douglas S Reintgen
Sophie Dessureault
P2860
P356
10.1177/107327480200900104
P577
2002-01-01T00:00:00Z